3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
35
Rectal Neoplasms
24
Stomach Neoplasms
19
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
12
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Nasopharyngeal Carcinoma
7
Adenocarcinoma Of Esophagus
7
Neoplasms
6
Colonic Neoplasms
6
Biliary Tract Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Interventions
Taxes
1
Standard of Care
1
Panitumumab
1
Pancreaticoduodenectomy
1
Optical Imaging
1
Losartan
1
Gemcitabine
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Capecitabine
×
90 days
×
Clear all
No trials found.